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Abstract
Recent studies demonstrated the expression of the insulin receptor (InsR) and its functional interaction with the transient
receptor potential vanilloid type 1 receptor (TRPV1) in primary sensory neurons (PSNs). The present study was undertaken
to reveal the target-specific expression of the InsR and its co-localization with the TRPV1 in rat PSNs. We assessed the
localization of the InsR and its co-localization with the TRPV1 in PSNs retrogradely labelled with biotin-conjugated wheat
germ agglutinin injected into the dorsal hind paw skin, the gastrocnemius muscle, the pancreas and the urinary bladder wall.
The largest proportions of retrogradely labelled InsR-immunoreactive neurons were identified among PSNs serving the
pancreas (~ 54%) and the urinary bladder (~ 53%). The proportions of retrogradely labelled InsR-immunoreactive neurons
innervating the dorsal hind paw skin and the gastrocnemius muscle amounted to ~ 22 and ~ 21%. TRPV1-immunoreactive
neurons amounted to ~ 63, ~ 62, ~ 67 and ~ 65% of retrogradely labelled cutaneous, muscle, pancreatic and urinary bladder
PSNs, respectively. Co-localization of the TRPV1 with the InsR was observed in ~ 16, ~ 15, ~ 29 and ~ 30% of retrogradely
labelled cutaneous, muscle, pancreatic and urinary bladder PSNs. These quantitative immunohistochemical data demon-
strate a preponderance of InsR-immunoreactivity among PSNs, which innervate visceral targets. The present findings
suggest that visceral spinal PSNs are more likely to be exposed to the modulatory effects of insulin on sensory functions,
including neurotrophic, nociceptive and inflammatory processes.
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Introduction
Insulin, apart from being a pivotal regulator of body metabo-
lism, is significantly involved in various neuronal processes,
such as neuronal survival, initiation of neurite outgrowth and
regulation of neuronal activity (Recio-Pinto et al. 1986;
Fernyhough et al. 1993; Wan et al. 1997; Barber et al. 2001;
Stella et al. 2001). Recently, it has also been revealed that
neural actions of insulin are mediated by the InsR, which
has been demonstrated in the nerve tissue, too (Sugimoto et
al. 2000; Figlewicz 2016). Insulin, at physiological concentra-
tions, enhances neurite outgrowth of cultured primary sensory
neurons (PSNs) (Fernyhough et al. 1993; Singh et al. 2012)
and exerts trophic effects on a specific subpopulation of PSNs
that is sensitive to nerve growth factor (NGF) (Recio-Pinto et
al. 1984; Recio-Pinto and Ishii 1988; Fernyhough et al. 1993).
In addition, experiments on cultured rat PSNs demonstrated
that insulin enhances the capsaicin-induced cobalt uptake
resulting from the activation of the nociceptive ion channel,
the transient receptor potential vanilloid type 1 receptor
(TRPV1) (Sathianathan et al. 2003). TRPV1-expressing
PSNs comprise about 60% of C-fibre ganglion neurons and
transmit nerve impulses generated by noxious heat and painful
chemical stimuli in somatic and visceral organs (Jancsó et al.
1977; Buck and Burks 1986; Holzer 1991; Caterina and Julius
2001). In addition to being essential in the transmission of
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nociceptive information towards the central nervous system,
this particular class of PSNs is implicated in the initiation and
maintenance of sensory neurogenic vascular and inflammato-
ry reactions collectively termed the neurogenic inflammatory
response (Jancsó et al. 1967, 1977; Holzer 1991). Further, it
has been reported that nociceptive afferent nerves may also
promote secretory, contractile and immune functions in the
innervated organs (Maggi and Meli 1988; Holzer 1991;
Nagy et al. 2004).
Several studies suggest that interactions among insulin, the
InsR and the TRPV1expressed in PSNSs may contribute to
physiological and pathophysiological processes including, for
example, inflammatory changes of the skin (Gamse et al.
1987; Santicioli et al. 1987), the dura mater (Dux et al.
2007) and the exocrine and endocrine pancreas (Nathan et
al. 2001; Razavi et al. 2006; Gram et al. 2007; Tsui et al.
2007). Immunohistochemical studies provided further support
to this notion by showing a substantial co-localization of the
TRPV1 and the InsR in rat and mouse PSNs of unidentified
target innervation territories (Sugimoto et al. 2002; Sántha and
Nagy 2006; Baiou et al. 2007) and in rat pancreatic spinal and
vagal PSNs (Lázár et al. 2018).
The expression of the InsR in nociceptive sensory nerves of
different organs and tissues may bear particular interest as
regards the modulatory influence of the ubiquitous metabolic
hormone insulin on a variety of tissue processes, in particular
on pain and inflammation. Hence, exploring the localization
of InsRs in PSNs serving somatic and visceral organs is of
critical importance for the further understanding of the role of
these particular afferent nerves under physiological and path-
ological conditions. Therefore, the aim of the present study is
to reveal the expression of InsRs in rat cutaneous, muscle,
pancreatic and urinary bladder afferent neurons and its co-
localization with the TRPV1.
Materials and methods
All experiments were approved by the Ethics Committee for
Animal Care at the University of Szeged and were carried out
in full accordance with the Directive 2010/63/EU of the
European Parliament and of the Council on the Protection of
Animals Used for Scientific Purposes and the guidelines of the
Committee for Research. All efforts were made to minimise
animal suffering. The number of experimental animals was
kept as low as possible.
Retrograde labelling of somatic and visceral
spinal primary sensory neurons
Adult male Wistar rats (n = 12), weighing 300–350 g,
were anaesthetised with isoflurane (Forene™, AbbVie
Hungary Ltd., Budapest, Hungary). To identify cutaneous,
muscle and visceral afferents, biotin-conjugated wheat
germ agglutinin (bWGA; Sigma-Aldrich, Gillingham,
UK, 1% in distilled water) was injected into the dorsal
hind paw skin, the gastrocnemius muscle, the urinary
bladder wall and the pancreas using a Hamilton
microsyringe. For labelling of dorsal root ganglion
(DRG) neurons serving the skin, 2 × 2-μl bWGA solution
was injected into the dorsal hind paw skin. The gastroc-
nemius muscle was exposed through an incision at the
dorsal aspect of the calf and 2 × 2-μl bWGA solution
was injected into the muscle. To label DRG neurons in-
nervating the pancreas or the urinary bladder, these organs
were exposed through a midline abdominal incision and
4 × 2-μl bWGA solution was injected into the parenchyma
of the pancreas or the urinary bladder wall. Thereafter, the
exposed area was thoroughly rinsed with saline and the
wound was closed in layers. After recovery from anaes-
thesia, the rats were returned to the animal house. Three
days later, the rats were anaesthetised with an overdose of
thiopental sodium (Insera Arzneimittel GmbH, Freiburg,
Germany) (150 mg/kg i.p.) and perfused transcardially
first with 100-ml saline, followed by 4% paraformalde-
hyde in 0.1-M phosphate buffer (pH 7.4). Selected
DRGs were removed, post-fixed for 2 h and stored in
0.1-M phosphate buffer (pH 7.4). Twenty-four hours be-
fore sectioning, the specimens were transferred into a
sucrose-buffer solution.
Serial frozen sections, 15 μm in thickness, were cut on a
cryostat and processed for immunohistochemistry. The L3–L5
(Gamse et al. 1982; Swett et al. 1991), L4–5 (Peyronnard et al.
1986; Swett et al. 1991), L3-S1 (Jancsó and Maggi 1987) and
Th10–13 (Won et al. 1998; Takamido et al. 2006; Lázár et al.
2018) DRGs were used to analyse the proportions of InsR-
and TRPV1-immunoreactive neurons, which innervate the
dorsal hind paw skin, the gastrocnemius muscle, the pancreas
and the urinary bladder, respectively.
Immunohistochemistry
Sections were rinsed in phosphate buffered saline (PBS) for
2 × 10 min, incubated in PBS containing 10% horse serum
and 0.1% Triton X-100 for 30 min and processed for staining
with the indirect immunofluorescence technique using the fol-
lowing antibodies: rabbit anti-InsR α subunit antibody (Santa
Cruz Biotechnologies, Dallas, Tex., USA; 1:500), guinea pig
anti-TRPV1 antibody (Neuromics, Edina, Minn., USA;
1:1500). The specificity of these antisera were assessed in
DRG sections by the lack of staining with the TRPV1 anti-
body in specimens obtained from TRPV1−/− mice and by the
failure of staining with the InsR antibody after preincubation
with the immunising peptide supplied by the manufacturer
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(Baiou et al. 2007). Donkey anti-rabbit IgG labelled with
DL488 (1:500) and donkey anti-guinea pig IgG labelled with
Cy3 (1:500) were used as secondary antibodies (all from
Jackson Immunoresearch Laboratories, West Grove, Pa.,
USA). bWGA lectin was detected by using an extravidine-
AMCA conjugate (Jackson Immunoresearch Laboratories).
All antibodies were diluted in phosphate buffered saline con-
taining Triton X100 (0.3%). Sections were incubated in the
presence of the primary antibodies overnight followed by a 2-
h incubation with the secondary antibodies. Specimens were
covered with Prolong Gold antifade mounting medium
(Invitrogen, Carlsbad, CA, USA).
Analysis of identified somatic and visceral
primary sensory neurons
Systemic random serial photomicrographs were taken with a
Leica DMLB fluorescence microscope (Wetzlar, Germany)
equipped with a Retiga 2000R digital camera (QImaging,
Surrey, B.C., Canada). bWGA-positive neurons with visible
nuclei were selected and analysis of retrogradely labelled neu-
rons was performed by using ImageJ (NIH; Bethesda, Md.,
USA; IJ1.46r) image analysis software. Values are expressed
as mean (standard deviation, SD). Statistical comparison of
data was performed with the Fisher’s exact probability test.
A p value of ≤ 0.05 was considered significant.
Results
Retrograde labelling of spinal PSNs innervating
somatic and visceral organs using bWGA
Injections of bWGA into the dorsal hind paw skin, the gas-
trocnemius muscle, the pancreas and the urinary bladder wall
resulted in the labelling of numerous neurons in the segmental
DRGs. We identified and analysed 147 neurons innervating
the dorsal hind paw skin (three animals), 138 neurons inner-
vating the gastrocnemius muscle (three animals), 174 neurons
innervating the pancreas (four animals) and 225 neurons in-
nervating the urinary bladder (four animals). The size frequen-
cy distribution of the labelled cells shows that bWGA identi-
fied small-medium sized neurons. The mean (SD) cross-
sectional area of the labelled cutaneous, muscle, pancreatic
and urinary bladder spinal PSNs amounted to 311.1 (43.4),
345.8 (55.9), 387.2 (49.4) and 339.2 (54.8) μm2. We analysed
the expression of the InsR and the TRPV1 in these retrograde-
ly labelled neurons. Figure 1 illustrates target-identified retro-
gradely labelled neurons examined in this study showing
InsR- and TRPV1-immunoreactivity.
InsR expression in retrogradely labelled spinal PSNs
Our quantitative data indicate that 22.4 (2.8) % of cutaneous,
21.8 (1.9) % of muscle, 54.1 (2.9) % of pancreatic and 53.4
(3.1) % of urinary bladder afferent neurons exhibited InsR
immunoreactivity (Fig. 2). We found that there were no sig-
nificant differences in the proportions of the InsR-
immunoreactive neurons either between cutaneous and mus-
cle afferents or between pancreatic and urinary bladder affer-
ents. However, the statistical analysis revealed a highly signif-
icant difference between proportions of InsR-immunoreactive
somatic and visceral afferent neurons (p < 0.05). We also
assessed the proportions of TRPV1-immunoreactiveneurons
in the bWGA-labelled InsR-immunoreactive neuron popula-
tion. In the DRGs, 72.7 (3.4), 73.3 (2.6), 54.3 (2.9) and 57.1
(3.6) % of the bWGA-labelled InsR-immunoreactive neurons
innervating the dorsal hind paw skin, the gastrocnemius mus-
cle, the pancreas and the urinary bladder showed TRPV1 im-
munoreactivity, respectively (Table 1). We found no signifi-
cant differences in TRPV1 expression among the four popu-
lations of neurons.
TRPV1 labelling of identified spinal PSNs
The large majority of identified PSNs expressed the TRPV1.
We found that 63.1 (3.4) % of cutaneous, 62.5 (2.7) % of
muscle, 66.9 (2.5) % of pancreatic and 65.0 (1.8) % of urinary
bladder bWGA-labelled afferents displayed TRPV1 immuno-
reactivity (Fig. 2). There were no significant differences in the
TRPV1 immunoreactivity among the subpopulations. We
analysed InsR immunoreactivity of the retrogradely labelled
TRPV1-positive neurons as well. In the dorsal root ganglia,
25.8 (2.2), 25.5 (2.4), 43.9 (2.3) and 46.6 (1.9) % of the
bWGA-labelled TRPV1-immunoreactive neurons innervating
the dorsal hind paw skin, the gastrocnemius muscle, the pan-
creas and the urinary bladder showed InsR-immunoreactivity,
respectively (Table 2). We found that there were no significant
differences in the proportions of the InsR-immunoreactive
neurons either between the cutaneous and the muscle afferents
or between the pancreatic and urinary bladder afferents.
However, the differences between the cutaneous and pancre-
atic, the cutaneous and bladder, the muscle and pancreatic and
muscle and urinary bladder PSNs were significant (p < 0.05).
Co-localization of the InsR with the TRPV1
in retrogradely labelled somatic and visceral spinal
PSNs
Through analysing the co-expression of the InsR with the
TRPV1 in retrogradely labelled cells, we found that 16.56
(0.6) % of cutaneous, 15.33 (1.1) % of muscle, 29.4 (1.8) %
of pancreatic and 30.34 (2.1) % of urinary bladder afferent
neurons exhibited both InsR and TRPV1 immunoreactivity,
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respectively (Fig. 2). There were no significant differences
either between the cutaneous and muscle or the pancreatic
and urinary bladder neurons. However, there were signifi-
cant differences in the proportion of the InsR- and TRPV-
immunoreactive neurons between the somatic and visceral
PSNs (p < 0.05).
Discussion
Recently, it has been revealed that InsR is expressed in rat and
mouse PSNS of unidentified target innervation territories
(Sugimoto et al. 2002; Sántha and Nagy 2006; Baiou et al.
2007) and in rat pancreatic spinal and vagal PSNs (Lázár et al.
2018). Our present quantitative immunohistochemical study
shows that up to 20% of the retrogradely labelled spinal PSNs
innervating the dorsal hind paw skin or the gastrocnemius
muscle express the InsR. The proportions of InsR-
immunoreactive neurons were significantly higher, amounting
up to 50%, among PSNs innervating visceral organs.
Similarly to previous data, our present observations show that
a relatively high proportion of PSNs expresses the InsR. In
addition, we found differential expression of the InsR in PSNs
innervating somatic and visceral organs, respectively. In PC12
cells, which share characteristics with nociceptive PSNs, the
InsR has recently been shown to form a complex with TrkA,
the receptor activated by NGF (Geetha et al. 2013). NGF is
essential in the development of functional traits and neuro-
chemical phenotypes of nociceptive PSNs (Snider and
McMahon 1998). Moreover, the expression of the TRPV1
has been shown to be regulated by NGF (Michael and
Priestley 1999). It is conceivable to suggest that through
interacting with TrkA, the InsR contributes to the develop-
ment, differentiation and functional characteristics of nocicep-
tive PSNs.
In the present study, we also examined the TRPV1-
immunoreactivity of the identified InsR-expressing PSNs.
Our quantitative data revealed that up to 50% of identified
InsR-expressing spinal PSNs exhibit TRPV1 immunoreactiv-
ity and in this respect, a significant difference between somatic
and visceral neurons was not detected. Additionally, the anal-
ysis of the retrogradely labelled TRPV1-immunoreactive neu-
rons shows that almost half of the visceral but only a quarter of
the somatic TRPV1-immunoreactive PSNs exhibit the InsR.




innervating the dorsal hind paw
skin (a, b, c), the gastrocnemius
muscle (d, e, f), the pancreas (g, h,
i) and the urinary bladder (j, k, l)
showing immunoreactivities for
the insulin receptor (InsR) and the
transient receptor potential
vanilloid type 1 receptor
(TRPV1). The scale bar indicates
100 μm and applies to all
photomicrographs
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Regarding the cell size and the TRPV1 expression pattern of
the identified InsR-immunoreactive PSNs, it is highly likely
that these neurons are nociceptive in function.
It has been demonstrated that systemic and local applica-
tions of insulin induce vascular changes mediated by the re-
lease of calcitonin gene-related peptide (CGRP) from
capsaicin-sensitive PSNs (Salem and Dunbar 2002). It has
also been revealed that InsR by modulating intracellular sig-
nalling systems may activate TRPV1-expressing PSNs
(Heidenreich et al. 1990; Cesare et al. 1999; Chuang et al.
2001; Sathianathan et al. 2003). The present observations con-
firm the co-localization of the InsR with TRPV1 in PSNs
(Sántha and Nagy 2006; Baiou et al. 2007; Lázár et al.
2018) and extend previous findings by showing differential
co-localization of the InsR and the TRPV1 in somatic and
visceral afferents. The relatively high co-expression rate of
the InsR and the TRPV1 in spinal PSNs suggests a functional
interaction between these receptors that may modify local tis-
sue reactions effected by chemosensitive PSNs.
The expression of the InsR and the co-expression of the
InsR with the TRPV1 may also bear important pathophysi-
ological significance under conditions of unbalanced plas-
ma insulin level. Insulin, through an action on TRPV1 sig-
nalling, may elicit a release of pro-inflammatory neuropep-
tides, such as CGRP (Salem and Dunbar 2002). This inter-
play may be important under hyperinsulinaemic conditions,
such as the initial phase of type 2 diabetes mellitus.
Furthermore, insulin-induced activation of TRPV1 may be
Fig. 2 Pie charts show the
percentage distribution of
populations of retrogradely
labelled primary sensory neurons
(PSNs) innervating the dorsal
hind paw skin (a), the
gastrocnemius muscle (b), the
pancreas (c) and the urinary
bladder (d). Pie charts were
constructed by analysing the
chemical phenotypes of 147 (a),
128 (b), 174 (c) and 225 (d)
retrogradely labelled cutaneous,
muscle, pancreatic and urinary
bladder PSNs




bladder and pancreatic primary
sensory neurons showing
transient receptor potential
vanilloid type 1 receptor
(TRPV1) immunoreactivity




Dorsal hind paw skin 33 72.7 (3.4)
Gastrocnemius muscle 30 73.3 (2.6)
Pancreas 94 54.3 (3.6)
Urinary bladder 119 57.1 (2.9)
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essential in keeping physiological functions of capsaicin-
sensitive sensory nerves (Sathianathan et al. 2003), which
may be affected under hypoinsulinaemic conditions, such as
in type 1 diabetes mellitus.
In recent years, many studies have focused on the role of
TRPV1 in inflammatory processes of both the exocrine and
the endocrine pancreas (Nathan et al. 2001; Razavi et al.
2006; Wick et al. 2006; Tsui et al. 2007; Iwasaki et al.
2013; Schwartz et al. 2013). More recently, it was also
hypothesised that insulin, by modulating TRPV1 activa-
tion, has a pivotal role in the initiation of pancreatitis
(Razavi et al. 2006; Tsui et al. 2007; Lázár et al. 2018).
Our morphological findings demonstrating a high degree
of co-localization of the InsR with the TRPV1 in neurons
innervating the pancreas support this assumption. Similarly,
diabetic cystopathy resulting in increased post-voiding re-
sidual volumes and enhanced urinary bladder capacity is
accompanied by decreased bladder sensation and contrac-
tion secondary to damage of visceral afferent fibres in the
urinary bladder wall (Kebapci et al. 2007). This assumption
is supported by observations of increased bladder capacity
and disturbances in urinary bladder reflexes and micturition
after neonatal capsaicin treatment (Jancsó and Maggi 1987;
Maggi et al. 1993), which produces a selective loss of noci-
ceptive C-fibre PSNs (Jancsó et al. 1977; Jancsó and Maggi
1987). Our findings, showing that ~ 50% of TRPV1-
immunoreactive neurons co-express the InsRs, suggest a
possible modulatory influence of insulin on urinary bladder
sensory nerves.
In conclusion, the present study demonstrates that a higher
proportion of visceral PSNs express the InsR as compared to
somatic ones and that TRPV1-expressing visceral afferent neu-
rons show a higher InsR expression rate than somatic PSNs.
Taking these morphological observations into consideration, it
could be hypothesised that the TRPV1-dependent functions of
visceral PSNs are more sensitive to changes in plasma insulin
levels and these neurons may be more susceptible to an inter-
play of the InsR and the TRPV1 under pathological conditions.
In addition, regarding the newly found co-localization of the
InsR and the TRPV1in identified visceral afferent neurons and
the functional interactions between these two receptors, a role
of InsR-expressing visceral sensory nerves in the development
of visceral inflammatory processes may emerge.
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